~~<i id='A74F5B8C34'><strike id='A74F5B8C34'><tt id='A74F5B8C34'><pre id='A74F5B8C34'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

fashion

author：focus 2025-09-30 21:22:28 - browse：94

Sarepta Therapeutics said Monday afternoon that its gene therapy for Duchenne muscular dystrophy failed to improve muscle function compared to a placebo in a large clinical trial — likely a major disappointment for patients and doctors who have been desperately awaiting the treatment for years.

The company said all patients in the study improved and that secondary measurements indicated the drug was having an effect. Nevertheless, the results are likely to raise questions about whether the Food and Drug Administration will expand access to the medicine.

Trading in Sarepta shares was halted at $107 with the release of the study results.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Skip the lead apron during X

Wikipedia

entertainment

focus

knowledge

explore

hotspot

AdobeTheUniversityofPennsylvania’sDivisionofRenal-ElectrolyteandHypertensionrecentlymadeaquietupdate

WSS

Drug cartel violence flares in western Mexico after vigilante leader's killing

Teladoc has a new CEO, but challenges remain the same

Use doctors trained outside the U.S. to ease the physician shortage

UpToDate has a racism problem: Dr. Stanley Goldfarb

How faith leaders like me can help address America's obesity epidemic

What affirmative action's end means to a medical student

hotspot

fashion

Wikipedia

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Being 'nonadherent' patient made me a more empathetic doctor

After affirmative action ruling, medical educators look to 'holistic review'

Hubble vs. James Webb telescope images: See the difference

Heart attack and stroke risk calculators need revising

How faith leaders like me can help address America's obesity epidemic

How one medical school became remarkably diverse

'Essentially witchcraft:' A former naturopath takes on the field

Medicare details structure of new drug price negotiation program

The system is set up to fail children with medical complexity

entertainment

Moderna says combo Covid

FDA reviewers ask if approval of Lilly’s Alzheimer’s drug should be restricted

Stephen Quake on the Chan Zuckerberg quest to conquer disease

Cancer thrives by mutating. But sometimes, a mutation leaves it vulnerable

STAT Virtual Event: ASCO Recap, Live!

My daughter's legacy lives on through her writing, phage therapy

focus

knowledge

explore

hotspot